Header cover image

U.S. Biotech Industry Analysis

UpdatedJul 13, 2025
DataAggregated Company Financials
Companies565
  • 7D1.4%
  • 3M6.7%
  • 1Y-11.6%
  • YTD0.7%

The Biotech industry is up 1.4% in the last week, with AbbVie up 1.7%. In the past year, the industry is down 12%. Looking forward, earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the U.S. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 13 Jul 2025US$973.9bUS$155.8b-US$23,414,756,764.1818.1x-41.6x6.3x
Tue, 10 Jun 2025US$952.0bUS$155.9b-US$23,940,289,678.7417x-39.8x6.1x
Thu, 08 May 2025US$890.3bUS$155.1b-US$25,574,283,733.6818.6x-34.8x5.7x
Sat, 05 Apr 2025US$774.2bUS$118.6b-US$37,107,737,767.7320.1x-20.9x6.5x
Mon, 03 Mar 2025US$850.8bUS$118.9b-US$37,265,127,499.9717x-22.8x7.2x
Wed, 29 Jan 2025US$991.6bUS$149.5b-US$26,314,079,099.9617.5x-37.7x6.6x
Fri, 27 Dec 2024US$990.4bUS$149.9b-US$26,370,197,964.7716.1x-37.6x6.6x
Sun, 24 Nov 2024US$1.0tUS$150.0b-US$26,558,578,256.4416.6x-38.3x6.8x
Tue, 22 Oct 2024US$908.0bUS$113.1b-US$36,019,658,167.4321.3x-25.2x8x
Thu, 19 Sep 2024US$925.6bUS$113.2b-US$35,972,157,840.1222.6x-25.7x8.2x
Sat, 17 Aug 2024US$882.4bUS$113.2b-US$35,765,976,434.6822.3x-24.7x7.8x
Mon, 15 Jul 2024US$1.2tUS$164.5b-US$28,105,214,748.9029.4x-42.5x7.3x
Wed, 12 Jun 2024US$1.2tUS$164.5b-US$26,795,949,828.0928.2x-43.3x7.1x
Fri, 10 May 2024US$1.1tUS$164.8b-US$26,733,495,747.4523.2x-41.9x6.8x
Sun, 07 Apr 2024US$1.1tUS$164.4b-US$23,431,530,428.0321.3x-48.2x6.9x
Tue, 05 Mar 2024US$1.2tUS$167.9b-US$21,298,840,556.0315.9x-56x7.1x
Thu, 01 Feb 2024US$1.4tUS$204.7b-US$22,672,999,235.0017.8x-63.6x7x
Sat, 30 Dec 2023US$1.4tUS$204.9b-US$22,199,644,413.0019.8x-62.9x6.8x
Mon, 27 Nov 2023US$1.2tUS$204.8b-US$22,013,452,568.0018.6x-55.7x6x
Wed, 25 Oct 2023US$1.2tUS$207.5b-US$13,040,888,319.0016.2x-93x5.8x
Fri, 22 Sep 2023US$1.3tUS$207.5b-US$12,875,537,971.0017.1x-98.4x6.1x
Sun, 20 Aug 2023US$1.3tUS$207.6b-US$12,372,676,716.0017.6x-102.2x6.1x
Tue, 18 Jul 2023US$1.1tUS$186.7b-US$15,958,556,257.0012.9x-71.1x6.1x
Thu, 15 Jun 2023US$1.2tUS$186.1b-US$15,929,018,280.0011.7x-72.3x6.2x
Sat, 13 May 2023US$1.2tUS$191.7b-US$12,347,110,804.0013.8x-93.5x6x
Mon, 10 Apr 2023US$1.2tUS$198.3b-US$3,291,225,770.0014x-353.5x5.9x
Wed, 08 Mar 2023US$1.1tUS$198.7b-US$5,119,400,088.0015.9x-221.2x5.7x
Fri, 03 Feb 2023US$1.2tUS$203.9bUS$1.8b14.9x642.4x5.7x
Sun, 01 Jan 2023US$1.1tUS$203.5bUS$1.7b14.3x663.5x5.6x
Tue, 29 Nov 2022US$1.1tUS$202.3bUS$1.3b14.7x841.8x5.5x
Thu, 27 Oct 2022US$1.1tUS$206.5bUS$6.4b14.1x171.7x5.3x
Sat, 24 Sep 2022US$1.0tUS$206.0bUS$5.6b13.9x182.3x4.9x
Mon, 22 Aug 2022US$1.1tUS$206.4bUS$7.3b16x147.7x5.2x
Wed, 20 Jul 2022US$1.1tUS$211.3bUS$10.6b17.2x102.8x5.2x
Price to Earnings Ratio

102.8x


Total Market Cap: US$1.1tTotal Earnings: US$10.6bTotal Revenue: US$211.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Biotech Industry Price to Earnings3Y Average 47.1x202320242025
Current Industry PE
  • Investors are relatively neutral on the American Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 6.4x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 9.7% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market-0.51%
Healthcare-0.27%
Biotech1.37%
Biotech1.37%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ABBV AbbVieUS$192.451.7%
+US$5.6b
13.0%PE81.8x
VRTX Vertex PharmaceuticalsUS$468.852.0%
+US$2.4b
-4.1%PS10.8x
REGN Regeneron PharmaceuticalsUS$567.743.7%
+US$2.2b
-48.4%PE13.3x
RYTM Rhythm PharmaceuticalsUS$86.7031.8%
+US$1.5b
73.3%PS41.6x
MRNA ModernaUS$33.6410.3%
+US$1.2b
-72.3%PS4.1x

Latest News